5.02
price down icon2.90%   -0.15
after-market Handel nachbörslich: 5.01 -0.010 -0.20%
loading
Schlusskurs vom Vortag:
$5.17
Offen:
$5.18
24-Stunden-Volumen:
1.08M
Relative Volume:
0.52
Marktkapitalisierung:
$785.05M
Einnahmen:
$181.41M
Nettoeinkommen (Verlust:
$-59.56M
KGV:
-11.95
EPS:
-0.42
Netto-Cashflow:
$-38.83M
1W Leistung:
-1.76%
1M Leistung:
+6.58%
6M Leistung:
+45.51%
1J Leistung:
+96.48%
1-Tages-Spanne:
Value
$4.99
$5.18
1-Wochen-Bereich:
Value
$4.99
$5.235
52-Wochen-Spanne:
Value
$2.095
$6.07

Xeris Biopharma Holdings Inc Stock (XERS) Company Profile

Name
Firmenname
Xeris Biopharma Holdings Inc
Name
Telefon
844-445-5704
Name
Adresse
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL
Name
Mitarbeiter
394
Name
Twitter
@XerisPharma
Name
Nächster Verdiensttermin
2024-12-08
Name
Neueste SEC-Einreichungen
Name
XERS's Discussions on Twitter

Vergleichen Sie XERS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
XERS
Xeris Biopharma Holdings Inc
5.02 828.00M 181.41M -59.56M -38.83M -0.42
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Xeris Biopharma Holdings Inc Stock (XERS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-11-11 Herabstufung Piper Sandler Overweight → Neutral
2024-03-28 Eingeleitet Oppenheimer Outperform
2023-08-28 Eingeleitet Craig Hallum Buy
2022-10-21 Eingeleitet Jefferies Buy
2022-04-28 Eingeleitet Craig Hallum Buy
2021-11-17 Eingeleitet SVB Leerink Outperform
2021-10-29 Eingeleitet H.C. Wainwright Buy
2021-04-07 Fortgesetzt RBC Capital Mkts Outperform
2020-02-18 Eingeleitet Piper Sandler Overweight
2018-07-16 Eingeleitet Jefferies Buy
2018-07-16 Eingeleitet Leerink Partners Outperform
2018-07-16 Eingeleitet RBC Capital Mkts Outperform
Alle ansehen

Xeris Biopharma Holdings Inc Aktie (XERS) Neueste Nachrichten

pulisher
Jul 26, 2025

Why Xeris Biopharma Holdings Inc. stock attracts strong analyst attentionFree Financial Group - Metal.it

Jul 26, 2025
pulisher
Jul 26, 2025

Cwm LLC Increases Stock Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Jul 26, 2025
pulisher
Jul 25, 2025

Is Xeris Biopharma Holdings Inc. a good long term investmentDouble or triple returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Will Xeris Biopharma Holdings Inc. stock split in the near futureGame-changing capital returns - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

What analysts say about Xeris Biopharma Holdings Inc. stockFree Trend-Following Techniques - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Xeris Biopharma Holdings Inc. Stock Analysis and ForecastExplosive capital gains - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Xeris Biopharma Holdings Inc. stock pricePowerful profit generation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

How Xeris Biopharma Holdings Inc. stock performs during market volatilitySmall Risk Large Return Trades - Newser

Jul 22, 2025
pulisher
Jul 21, 2025

Xponance Inc. Invests $57,000 in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Jul 21, 2025
pulisher
Jul 16, 2025

how xeris biopharma holdings inc. stock performs during market volatilityMarket Timing Advice - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

why xeris biopharma holdings inc. stock attracts strong analyst attentionMassive Upside Selection - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Brown Advisory Inc. Has $630,000 Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Xeris Biopharma Holdings Inc. stock price move sharplyBreakout Momentum Stocks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

A Piece Of The Puzzle Missing From Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) 25% Share Price Climb - simplywall.st

Jul 15, 2025
pulisher
Jul 14, 2025

Xeris Biopharma's 7% Spike: Unraveling the Mysterious Move - AInvest

Jul 14, 2025
pulisher
Jul 10, 2025

Wealth Enhancement Advisory Services LLC Has $172,000 Holdings in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Jul 10, 2025
pulisher
Jul 09, 2025

Xeris Biopharma's 10% Spike: A Technical and Market Flow Deep Dive - AInvest

Jul 09, 2025
pulisher
Jul 08, 2025

Xeris Biopharma (NASDAQ:XERS) versus Mangoceuticals (NASDAQ:MGRX) Head to Head Review - Defense World

Jul 08, 2025
pulisher
Jun 28, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Jun 28, 2025
pulisher
Jun 20, 2025

Rhumbline Advisers Increases Stock Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Jun 20, 2025
pulisher
Jun 19, 2025

Wealth Enhancement Advisory Services LLC Raises Holdings in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Jun 19, 2025
pulisher
Jun 18, 2025

Xeris Biopharma: Great Numbers, Great Technologies, And Suitable For Long-Term Investing - Seeking Alpha

Jun 18, 2025
pulisher
Jun 18, 2025

Xeris Biopharma (NASDAQ:XERS) Stock Price Up 8.4% Following Insider Buying Activity - Defense World

Jun 18, 2025
pulisher
Jun 15, 2025

Pallas Capital Advisors LLC Acquires New Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Jun 15, 2025
pulisher
Jun 09, 2025

Squarepoint Ops LLC Has $138,000 Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

Two Sigma Advisers LP Makes New Investment in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

Leerink Partnrs Estimates Xeris Biopharma FY2025 Earnings - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Leerink Partnrs Forecasts Lower Earnings for Xeris Biopharma - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Xeris Biopharma (NASDAQ:XERS) Stock Price Down 5.5%Should You Sell? - MarketBeat

Jun 06, 2025
pulisher
Jun 05, 2025

Leerink Partners raises Xeris Pharmaceuticals stock price target By Investing.com - Investing.com UK

Jun 05, 2025
pulisher
Jun 05, 2025

Transcript : Xeris Biopharma Holdings, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 01 - MarketScreener

Jun 05, 2025
pulisher
Jun 04, 2025

Xeris at Jefferies Conference: Strategic Growth and Future Prospects By Investing.com - Investing.com Canada

Jun 04, 2025
pulisher
Jun 04, 2025

xeris biopharma holds annual meeting, elects directors By Investing.com - Investing.com South Africa

Jun 04, 2025

Finanzdaten der Xeris Biopharma Holdings Inc-Aktie (XERS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Kapitalisierung:     |  Volumen (24h):